These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 16186599

  • 1. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
    Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, Walker RC, Ansell SM, Macon WR, Gores GG, Stegall MD, McGregor CG.
    J Clin Oncol; 2005 Oct 20; 23(30):7574-82. PubMed ID: 16186599
    [Abstract] [Full Text] [Related]

  • 2. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G, Cantoni S, Oreste P, Klersy C, Gini G, Rossi V, D'Avanzo G, Comoli P, Baldanti F, Montillo M, Nosari A, Morra E, Cooperative Study Group on PTLDs.
    Haematologica; 2002 Jan 20; 87(1):67-77. PubMed ID: 11801467
    [Abstract] [Full Text] [Related]

  • 3. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 4. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 5. Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
    Choquet S, Oertel S, LeBlond V, Riess H, Varoqueaux N, Dörken B, Trappe R.
    Ann Hematol; 2007 Aug 10; 86(8):599-607. PubMed ID: 17522862
    [Abstract] [Full Text] [Related]

  • 6. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.
    Clin Transplant; 2005 Jun 10; 19(3):327-34. PubMed ID: 15877793
    [Abstract] [Full Text] [Related]

  • 7. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
    Fohrer C, Caillard S, Koumarianou A, Ellero B, Woehl-Jaeglé ML, Meyer C, Epailly E, Chenard MP, Lioure B, Natarajan-Ame S, Maloisel F, Lutun P, Kessler R, Moulin B, Bergerat JP, Wolf P, Herbrecht R.
    Br J Haematol; 2006 Sep 20; 134(6):602-12. PubMed ID: 16889621
    [Abstract] [Full Text] [Related]

  • 9. Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.
    Buadi FK, Heyman MR, Gocke CD, Rapoport AP, Hakimian R, Bartlett ST, Sarkodee-Adoo C.
    Am J Hematol; 2007 Mar 20; 82(3):208-14. PubMed ID: 17022049
    [Abstract] [Full Text] [Related]

  • 10. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
    Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA.
    Cancer; 2005 Oct 15; 104(8):1661-7. PubMed ID: 16149091
    [Abstract] [Full Text] [Related]

  • 11. A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation.
    Orjuela M, Gross TG, Cheung YK, Alobeid B, Morris E, Cairo MS.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3945S-52S. PubMed ID: 14506193
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 01; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
    Yoon SO, Yu E, Cho YM, Suh C, Kim KM, Han DJ, Lee SG, Huh J.
    Clin Transplant; 2012 Oct 01; 26(1):67-73. PubMed ID: 21269330
    [Abstract] [Full Text] [Related]

  • 15. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z, Amlot P, Lachmanan SR, Tur-Kaspa R, Rolles K, Burroughs AK.
    Liver Transpl Surg; 1999 May 01; 5(3):184-91. PubMed ID: 10226108
    [Abstract] [Full Text] [Related]

  • 16. [Identification of prognostic factors in post-transplantation lymphoproliferative disorders].
    Choquet S, Levy V, Leblond V.
    Bull Cancer; 2004 Apr 01; 91(4):373-8. PubMed ID: 15242322
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
    Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL.
    Clin Transplant; 2012 Apr 01; 26(5):679-83. PubMed ID: 22324300
    [Abstract] [Full Text] [Related]

  • 18. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R, Riess H, Babel N, Hummel M, Lehmkuhl H, Jonas S, Anagnostopoulos I, Papp-Vary M, Reinke P, Hetzer R, Dörken B, Oertel S.
    Transplantation; 2007 Apr 15; 83(7):912-8. PubMed ID: 17460562
    [Abstract] [Full Text] [Related]

  • 19. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.
    Hepatogastroenterology; 2000 Apr 15; 47(31):211-9. PubMed ID: 10690611
    [Abstract] [Full Text] [Related]

  • 20. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE, Thomas W, Defor TE, Weisdorf DJ, Burns LJ.
    Biol Blood Marrow Transplant; 2007 Apr 15; 13(4):486-92. PubMed ID: 17382255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.